Streetbeat News

Earnings

DSP

Viant Technology projects its Q1 2024 revenue to be between $49M and $52M, surpassing the estimated $48.224M.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:40 pm

AKYA

Akoya Biosciences projects its full year 2024 revenue to be in the range of $114M-$118M, which is around the analyst estimate of $117.38M. The company also aims to achieve operating cash flow breakeven by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:40 pm

AVAV

AeroVironment Inc (NASDAQ:AVAV) reported a significant beat on both revenue and EPS for its fiscal third quarter, with a 39% year-over-year increase in revenue to $186.6 million and earnings of 63 cents per share. The company highlighted increased global demand, a strong backlog, and record revenue in the Loitering Munition Systems segment as key drivers. AeroVironment expects full-year 2024 revenue between $700 million and $710 million and adjusted earnings per share between $2.69 and $2.83, indicating continued growth.

Portfolio Pulse from Adam Eckert

March 04, 2024 | 9:37 pm

ICCH

ICC Holdings (NASDAQ:ICCH) reported a slight decrease in Q4 EPS to $1.04 from $1.05 YoY, while sales increased by 9.68% to $23.12M from $21.08M YoY.

Portfolio Pulse from Happy Mohamed

March 04, 2024 | 9:34 pm

ATER

FOSL

SFIX

TDUP

In Monday's after-market session, several consumer discretionary stocks showed notable movements. Aterian, Fossil Group, Interactive Strength, Rent the Runway, EpicQuest Education Group, and Newegg Commerce were among the gainers, with increases in their stock prices. On the other hand, ThredUp, Stitch Fix, BowFlex, BurgerFi International, Cato, and AMMO experienced declines, with ThredUp and Stitch Fix specifically reacting to their earnings releases.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:32 pm

CARA

EKSO

RBOT

In Monday's after-market session, health care stocks saw significant movements. Vicarious Surgical (RBOT) led the gainers with a 24.9% increase following their Q4 earnings report. Ekso Bionics Holdings (EKSO) and Jaguar Health (JAGX) also posted strong gains after their Q4 earnings. On the losing side, Cara Therapeutics (CARA) dropped 15% after its Q4 earnings, with Moleculin Biotech (MBRX) and Tandem Diabetes Care (TNDM) also experiencing declines.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:32 pm

AVAV

MNTS

RMCO

In Monday's after-market session, several industrials stocks saw significant movements. Momentus (MNTS) led the gainers with a 55.1% increase, while Royalty Management Holdings (RMCO) experienced the largest drop among the losers, falling 9.2%. Notably, AeroVironment (AVAV) saw a 16.99% rise following their Q3 earnings report.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:32 pm

DSP

GTLB

SEMR

In Monday's after-market session, several Information Technology stocks showed significant movement. Viant Technology, Phunware, CommScope Holding Co, Casa Systems, Sonim Technologies, and Intrusion experienced gains, with Viant Technology leading at an 8.9% increase following their Q4 earnings report. Conversely, GitLab, SEMrush Holdings, ARB IOT Group, MicroStrategy, Presto Automation, and inTest faced declines, with GitLab dropping 11.6% after their Q4 earnings announcement.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:32 pm

OFS

OFS Capital reported Q4 earnings of $0.35 per share, missing the consensus estimate of $0.39, and sales of $13.48M, below the $14.20M estimate. This represents a year-over-year earnings stagnation and a 3.68% decrease in sales.

Portfolio Pulse from Happy Mohamed

March 04, 2024 | 9:32 pm

SEMR

SEMrush Holdings (SEMR) reported Q4 2023 adjusted EPS of $0.050, surpassing the $0.040 estimate, with sales of $83.400M exceeding the $83.106M estimate, marking a 21.25% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:31 pm